AR Signaling in Human Malignancies: Prostate Cancer and Beyond
Abstract
:Conflicts of Interest
References
- Schweizer, M.T.; Yu, E.Y. AR-signaling in human malignancies: Prostate cancer and beyond. Cancers 2017, 9, 7. [Google Scholar] [CrossRef] [PubMed]
- Crumbaker, M.; Khoja, L.; Joshua, A.M. AR signaling and the PI3K pathway in prostate cancer. Cancers 2017, 9, 34. [Google Scholar] [CrossRef] [PubMed]
- Obinata, D.; Takayama, K.; Takahashi, S.; Inoue, S. Crosstalk of the androgen receptor with transcriptional collaborators: potential therapeutic targets for castration-resistant prostate cancer. Cancers 2017, 9, 22. [Google Scholar] [CrossRef] [PubMed]
- Eisermann, K.; Fraizer, G. The androgen receptor and VEGF: Mechanisms of androgen-regulated angiogenesis in prostate cancer. Cancers 2017, 9, 32. [Google Scholar] [CrossRef] [PubMed]
- Leach, D.A.; Buchanan, G. Stromal androgen receptor in prostate cancer development and progression. Cancers 2017, 9, 10. [Google Scholar] [CrossRef] [PubMed]
- Cucchiara, V.; Yang, J.C.; Mirone, V.; Gao, A.C.; Rosenfeld, M.G.; Evans, C.P. Epigenomic regulation of androgen receptor signaling: Potential role in prostate cancer therapy. Cancers 2017, 9, 9. [Google Scholar] [CrossRef] [PubMed]
- Pakula, H.; Xiang, D.; Li, Z. A tale of two signals: AR and WNT in development and tumorigenesis of prostate and mammary gland. Cancers 2017, 9, 14. [Google Scholar] [CrossRef] [PubMed]
- Rahim, B.; O’Regan, R. AR signaling in breast cancer. Cancers 2017, 9, 21. [Google Scholar] [CrossRef] [PubMed]
- Narayanan, R.; Dalton, J.T. Androgen receptor: A complex therapeutic target for breast cancer. Cancers 2016, 8, 108. [Google Scholar] [CrossRef] [PubMed]
- Asano, Y.; Kashiwagi, S.; Goto, W.; Tanaka, S.; Morisaki, T.; Takashima, T.; Noda, S.; Onoda, N.; Ohsawa, M.; Hirakawa, K.; Ohira, M. Expression and clinical significance of androgen receptor in triple-negative breast cancer. Cancers 2017, 9, 4. [Google Scholar] [CrossRef] [PubMed]
- Li, P.; Chen, J.; Miyamoto, H. Androgen receptor signaling in bladder cancer. Cancers 2017, 9, 20. [Google Scholar] [CrossRef] [PubMed]
- Dalin, M.G.; Watson, P.A.; Ho, A.L.; Morris, L.G.T. Androgen Receptor signaling in salivary gland cancer. Cancers 2017, 9, 17. [Google Scholar] [CrossRef] [PubMed]
- Kanda, T.; Takahashi, K.; Nakamura, M.; Nakamoto, S.; Wu, S.; Haga, Y.; Sasaki, R.; Jiang, X.; Yokosuka, O. Androgen receptor could be a potential therapeutic target in patients with advanced hepatocellular carcinoma. Cancers 2017, 9, 43. [Google Scholar] [CrossRef] [PubMed]
© 2018 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Antonarakis, E.S. AR Signaling in Human Malignancies: Prostate Cancer and Beyond. Cancers 2018, 10, 22. https://doi.org/10.3390/cancers10010022
Antonarakis ES. AR Signaling in Human Malignancies: Prostate Cancer and Beyond. Cancers. 2018; 10(1):22. https://doi.org/10.3390/cancers10010022
Chicago/Turabian StyleAntonarakis, Emmanuel S. 2018. "AR Signaling in Human Malignancies: Prostate Cancer and Beyond" Cancers 10, no. 1: 22. https://doi.org/10.3390/cancers10010022
APA StyleAntonarakis, E. S. (2018). AR Signaling in Human Malignancies: Prostate Cancer and Beyond. Cancers, 10(1), 22. https://doi.org/10.3390/cancers10010022